BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25845827)

  • 1. A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834.
    Sodhi JK; Wong S; Kirkpatrick DS; Liu L; Khojasteh SC; Hop CE; Barr JT; Jones JP; Halladay JS
    Drug Metab Dispos; 2015 Jun; 43(6):908-15. PubMed ID: 25845827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton's tyrosine kinase inhibitor.
    Liu L; Halladay JS; Shin Y; Wong S; Coraggio M; La H; Baumgardner M; Le H; Gopaul S; Boggs J; Kuebler P; Davis JC; Liao XC; Lubach JW; Deese A; Sowell CG; Currie KS; Young WB; Khojasteh SC; Hop CE; Wong H
    Drug Metab Dispos; 2011 Oct; 39(10):1840-9. PubMed ID: 21742900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability.
    Young WB; Barbosa J; Blomgren P; Bremer MC; Crawford JJ; Dambach D; Eigenbrot C; Gallion S; Johnson AR; Kropf JE; Lee SH; Liu L; Lubach JW; Macaluso J; Maciejewski P; Mitchell SA; Ortwine DF; Di Paolo J; Reif K; Scheerens H; Schmitt A; Wang X; Wong H; Xiong JM; Xu J; Yu C; Zhao Z; Currie KS
    Bioorg Med Chem Lett; 2016 Jan; 26(2):575-579. PubMed ID: 26675441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarthritis effect of a novel Bruton's tyrosine kinase (BTK) inhibitor in rat collagen-induced arthritis and mechanism-based pharmacokinetic/pharmacodynamic modeling: relationships between inhibition of BTK phosphorylation and efficacy.
    Liu L; Di Paolo J; Barbosa J; Rong H; Reif K; Wong H
    J Pharmacol Exp Ther; 2011 Jul; 338(1):154-63. PubMed ID: 21521773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and selective Bruton's tyrosine kinase inhibitors: discovery of GDC-0834.
    Young WB; Barbosa J; Blomgren P; Bremer MC; Crawford JJ; Dambach D; Gallion S; Hymowitz SG; Kropf JE; Lee SH; Liu L; Lubach JW; Macaluso J; Maciejewski P; Maurer B; Mitchell SA; Ortwine DF; Di Paolo J; Reif K; Scheerens H; Schmitt A; Sowell CG; Wang X; Wong H; Xiong JM; Xu J; Zhao Z; Currie KS
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1333-7. PubMed ID: 25701252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of c-Met Kinase Inhibitors Containing Quinoline by Aldehyde Oxidase, Electron Donating, and Steric Hindrance Effect.
    Zhang JW; Xiao W; Gao ZT; Yu ZT; Zhang JYJ
    Drug Metab Dispos; 2018 Dec; 46(12):1847-1855. PubMed ID: 30209037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0834 and its metabolite in human plasma using semi-automated 96-well protein precipitation.
    Shin YG; Jones SA; Murakami SC; Liu L; Wong H; Buonarati MH; Hop CE
    Biomed Chromatogr; 2012 Nov; 26(11):1444-51. PubMed ID: 22311651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrite reductase activity of rat and human xanthine oxidase, xanthine dehydrogenase, and aldehyde oxidase: evaluation of their contribution to NO formation in vivo.
    Maia LB; Pereira V; Mira L; Moura JJ
    Biochemistry; 2015 Jan; 54(3):685-710. PubMed ID: 25537183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist PF-5190457: A Reverse Translational Bed-to-Bench Approach.
    Adusumalli S; Jamwal R; Obach RS; Ryder TF; Leggio L; Akhlaghi F
    Drug Metab Dispos; 2019 Aug; 47(8):874-882. PubMed ID: 31182423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing mGlu
    Crouch RD; Blobaum AL; Felts AS; Conn PJ; Lindsley CW
    Drug Metab Dispos; 2017 Dec; 45(12):1245-1259. PubMed ID: 28939686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refinement of In Vitro Methods for Identification of Aldehyde Oxidase Substrates Reveals Metabolites of Kinase Inhibitors.
    Dick RA
    Drug Metab Dispos; 2018 Jun; 46(6):846-859. PubMed ID: 29615437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde oxidase-dependent species difference in hepatic metabolism of fasudil to hydroxyfasudil.
    Mao Z; Wu Y; Li Q; Wang X; Liu Y; Di X
    Xenobiotica; 2018 Feb; 48(2):170-177. PubMed ID: 28166443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro oxidative metabolism of 6-mercaptopurine in human liver: insights into the role of the molybdoflavoenzymes aldehyde oxidase, xanthine oxidase, and xanthine dehydrogenase.
    Choughule KV; Barnaba C; Joswig-Jones CA; Jones JP
    Drug Metab Dispos; 2014 Aug; 42(8):1334-40. PubMed ID: 24824603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
    Strelevitz TJ; Orozco CC; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Going Beyond Common Drug Metabolizing Enzymes: Case Studies of Biotransformation Involving Aldehyde Oxidase, γ-Glutamyl Transpeptidase, Cathepsin B, Flavin-Containing Monooxygenase, and ADP-Ribosyltransferase.
    Fan PW; Zhang D; Halladay JS; Driscoll JP; Khojasteh SC
    Drug Metab Dispos; 2016 Aug; 44(8):1253-61. PubMed ID: 27117704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel amide-derivatized 2,4-bispyridyl thiophenes as highly potent and selective Dyrk1A inhibitors. Part II: Identification of the cyclopropylamide moiety as a key modification.
    Darwish SS; Abdel-Halim M; ElHady AK; Salah M; Abadi AH; Becker W; Engel M
    Eur J Med Chem; 2018 Oct; 158():270-285. PubMed ID: 30223116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.
    Klecker RW; Cysyk RL; Collins JM
    Bioorg Med Chem; 2006 Jan; 14(1):62-6. PubMed ID: 16143537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental changes of aldehyde oxidase activity and protein expression in human liver cytosol.
    Tayama Y; Sugihara K; Sanoh S; Miyake K; Kitamura S; Ohta S
    Drug Metab Pharmacokinet; 2012; 27(5):543-7. PubMed ID: 22453079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
    Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB
    Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans.
    Akabane T; Tanaka K; Irie M; Terashita S; Teramura T
    Xenobiotica; 2011 May; 41(5):372-84. PubMed ID: 21385103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.